Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...
A subsidiary of Sun Pharma has reached an agreement to buy the assets of Canada's Antibe Therapeutics, a developer of drugs ...
Sun Pharma is currently priced at Rs 1767.60, showing a modest rise of 1.19% today. The 3-day simple moving average is Rs ...
Hosted on MSN1mon
Meet Vidhi Shanghvi: Heir To Rs 4 Lakh Crore Pharma Empire And the Ambani Family ConnectionSPARC is a clinical-stage biopharmaceutical company established by Sun Pharma to focus on innovative medicines. Apart from her corporate responsibilities, Vidhi is also an advocate for mental health.
In addition to this leadership role, she is a non-executive director at Sun Pharma Advanced Research Company (SPARC), a subsidiary focused on clinical-stage biopharmaceutical products. Prior to ...
MUMBAI: After an 18-year whirlwind of success in banking marketing, Pulak Sarmah has made a bold leap into the pharmaceutical arena, becoming the head of corporate marketing & brand at Sun Pharma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback